Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
BMC Genomics|February 21, 2022
TC-hunter: identification of the insertion site of a transgenic gene within the host genomeVanja Börjesson, Angela Martinez-Monleon, Susanne Fransson, et al.
BMC Cancer|February 15, 2011
Identification of epigenetically regulated genes that predict patient outcome in neuroblastomaHelena Carén, Anna Djos, Maria Nethander, et al.
Cancer Research|October 20, 2004
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivoJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Cancer Letters|August 2, 2011
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cellsPaula Schiapparelli, Mehdi H Shahi, Mónica Enguita-Germán, et al.
Hereditary Cancer in Clinical Practice|January 21, 2020
Whole-body MRI within a surveillance program for carriers with clinically actionable germline <i>TP53</i> variants - the Swedish constitutional <i>TP53</i> study SWEP53Meis Omran, Lennart Blomqvist, Yvonne Brandberg, et al.
Pediatric Hematology and Oncology|May 9, 2018
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factorsKleopatra Georgantzi, Erik G Sköldenberg, Mats Stridsberg, et al.
BMC Cancer|May 10, 2013
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validationCihan Cetinkaya, Tommy Martinsson, Johanna Sandgren, et al.
Oncoimmunology|January 27, 2017
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockadeNina Eissler, Yumeng Mao, David Brodin, et al.
Cancers|January 1, 2020
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma GrowthCecilia Dyberg, Teodora Andonova, Thale Kristin Olsen, et al.
BMC Cancer|April 3, 2016
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastomaCecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
BMC Genomics|February 21, 2022
TC-hunter: identification of the insertion site of a transgenic gene within the host genomeVanja Börjesson, Angela Martinez-Monleon, Susanne Fransson, et al.
BMC Cancer|February 15, 2011
Identification of epigenetically regulated genes that predict patient outcome in neuroblastomaHelena Carén, Anna Djos, Maria Nethander, et al.
Cancer Research|October 20, 2004
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivoJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Cancer Letters|August 2, 2011
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cellsPaula Schiapparelli, Mehdi H Shahi, Mónica Enguita-Germán, et al.
Hereditary Cancer in Clinical Practice|January 21, 2020
Whole-body MRI within a surveillance program for carriers with clinically actionable germline <i>TP53</i> variants - the Swedish constitutional <i>TP53</i> study SWEP53Meis Omran, Lennart Blomqvist, Yvonne Brandberg, et al.
Pediatric Hematology and Oncology|May 9, 2018
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factorsKleopatra Georgantzi, Erik G Sköldenberg, Mats Stridsberg, et al.
BMC Cancer|May 10, 2013
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validationCihan Cetinkaya, Tommy Martinsson, Johanna Sandgren, et al.
Oncoimmunology|January 27, 2017
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockadeNina Eissler, Yumeng Mao, David Brodin, et al.
Cancers|January 1, 2020
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma GrowthCecilia Dyberg, Teodora Andonova, Thale Kristin Olsen, et al.
BMC Cancer|April 3, 2016
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastomaCecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, et al.
Pageof 17